A randomised, controlled, assessor-blind, parallel groups, multicentre, multinational trial comparing the efficacy and safety of FE 999049 with follitropin alfa (GONAL-F) in controlled ovarian stimulation in women undergoing an assisted reproductive technology programme
Latest Information Update: 08 Mar 2022
At a glance
- Drugs Follitropin delta (Primary) ; Follitropin alfa
- Indications Endometriosis; Female infertility
- Focus Registrational; Therapeutic Use
- Acronyms ESTHER-1
- Sponsors Ferring Pharmaceuticals
- 29 Jun 2021 Results published in the Ferring Pharmaceuticals Media Release.
- 29 Jun 2021 According to a Ferring Pharmaceuticals media release, data from this study were presented today at the 37th Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE).
- 21 Oct 2020 Results of pooled analysis from two studies including this study presented at the American Society for Reproductive Medicine Scientific Congress 2020.